Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pharming (PHAR) Operating Expenses (2020 - 2025)

Historic Operating Expenses for Pharming (PHAR) over the last 6 years, with Q3 2025 value amounting to $3.3 million.

  • Pharming's Operating Expenses rose 10913.56% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$282.0 million, marking a year-over-year decrease of 630.61%. This contributed to the annual value of $153.8 million for FY2024, which is 2324.37% up from last year.
  • Per Pharming's latest filing, its Operating Expenses stood at $3.3 million for Q3 2025, which was up 10913.56% from -$87.8 million recorded in Q2 2025.
  • In the past 5 years, Pharming's Operating Expenses ranged from a high of $57.3 million in Q4 2021 and a low of -$153.8 million during Q4 2024
  • For the 5-year period, Pharming's Operating Expenses averaged around -$40.2 million, with its median value being -$31.6 million (2023).
  • Per our database at Business Quant, Pharming's Operating Expenses plummeted by 12664092.49% in 2022 and then soared by 10913.56% in 2025.
  • Quarter analysis of 5 years shows Pharming's Operating Expenses stood at $57.3 million in 2021, then tumbled by 149.77% to -$28.5 million in 2022, then crashed by 337.86% to -$124.8 million in 2023, then decreased by 23.24% to -$153.8 million in 2024, then surged by 102.14% to $3.3 million in 2025.
  • Its Operating Expenses was $3.3 million in Q3 2025, compared to -$87.8 million in Q2 2025 and -$43.6 million in Q1 2025.